Learn about support and programs that may help you pay for GILOTRIF.

What you should know about lung cancer

A diagnosis of advanced (metastatic) non-small cell lung cancer (NSCLC) can be difficult and overwhelming for both you and your family. It is, however, important to keep positive and hopeful. You are not alone. Lung cancer is one of the most common of all cancers. And among the different types of lung cancer, NSCLC is the most common. With so many people affected by advanced NSCLC, the medical and research communities are working extremely hard to help the many people like you.

WHAT IS GILOTRIF?

GILOTRIF is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC) that:

• has certain (non-resistant) abnormal epidermal growth factor receptor (EGFR) gene(s). Your healthcare provider will perform a test to make sure that GILOTRIF is right for you.

• has spread to other parts of the body (metastatic), and

• has not been previously treated for metastatic lung cancer

It is not known if GILOTRIF is safe and effective in treating people with lung cancer that has resistant abnormal EGFR genes.

or

is used to treat people with squamous cell lung cancer that:

• has spread to other parts of the body, and

• has been previously treated with chemotherapy that contains platinum.


It is not known if GILOTRIF is safe and effective in children.

Find out about NSCLC

Understanding biomarker testing and EGFR mutations

Learn how NSCLC is treated